Papers in the journal EuroIntervention (Page 2)

#21

JOURNAL ARTICLE

Ischaemic and viability testing for guiding PCI are overrated: pros and cons.

Margaret B McEntegart, Anja Oksnes, Xavier Carrillo, Victoria Delgado

No abstract text is available yet for this article.

38506743

March 18, 2024: EuroIntervention

#22

EDITORIAL

Plug-based bailout after failed suture-based large-bore vascular access closure: one more arrow in the quiver for experienced hands?

Tobias Rheude, Erion Xhepa

No abstract text is available yet for this article.

38506742

March 18, 2024: EuroIntervention

#23

JOURNAL ARTICLE

A study of bailout plug-based closure after failed suture-based closure in patients undergoing transfemoral TAVI.

Oliver Dumpies, Ahmed Abdelhafez, Johannes Rotta Detto Loria, Ines Richter, Hans-Josef Feistritzer, Nicolas Majunke, Steffen Desch, Thilo Noack, Holger Thiele, Mohamed Abdel-Wahab

BACKGROUND: Percutaneous suture-based arterial access site closure (ProGlide) is commonly applied in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI). However, the failure of a suture-based vascular closure device (VCD) may require additional treatment. AIMS: We aimed to evaluate the efficacy and safety of bailout access site closure using a large-bore plug-based device (MANTA) in patients with failed suture-based closure during transfemoral TAVI...

38506741

March 18, 2024: EuroIntervention

#24

JOURNAL ARTICLE

Strategies to minimise bleeding secondary to large-bore vascular access complications: an ounce of prevention is worth a pound of cure.

Thomas Pilgrim, Annette Maznyczka

No abstract text is available yet for this article.

38506740

March 18, 2024: EuroIntervention

#25

JOURNAL ARTICLE

Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure.

David Meier, Daire Grant, Chris Frawley, Mariama Akodad, Uri Landes, Arif A Kokhar, Dariusz Dudek, Isaac George, Michael J Rinaldi, Won-Keun Kim, Steven J Yakubov, Paul Sorajja, Giuseppe Tarantini, David A Wood, John G Webb, Stephanie L Sellers, Janarthanan Sathananthan

BACKGROUND: There are limited data regarding treatment for failed balloon-expandable transcatheter heart valves (THVs) in redo-transcatheter aortic valve implantation (TAVI). AIMS: We aimed to assess THV performance, neoskirt height and expansion when performing redo-TAVI with the ACURATE platform inside a SAPIEN 3 (S3) compared to redo-TAVI with an S3 in an S3. METHODS: Redo-TAVI was performed on the bench using each available size of the S3, the ACURATE neo2 (ACn2) and the next-generation ACURATE Prime XL (AC XL) implanted at 2 different depths within 20 mm/23 mm/26 mm/29 mm S3s serving as the "failed" index THV...

38506739

March 18, 2024: EuroIntervention

#26

JOURNAL ARTICLE

Comparative preclinical assessment of drug-coated balloons: a blessing and a curse for clinical translation.

Michael Joner, Léa Wild

No abstract text is available yet for this article.

38506738

March 18, 2024: EuroIntervention

#27

MULTICENTER STUDY

Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry.

Won-Keun Kim, Moritz Seiffert, Andreas Rück, David M Leistner, Henryk Dreger, Hendrik Wienemann, Matti Adam, Helge Möllmann, Johannes Blumenstein, Clemens Eckel, Andrea Buono, Diego Maffeo, Antonio Messina, Andreas Holzamer, Samuel Sossalla, Giuliano Costa, Marco Barbanti, Silvia Motta, Corrado Tamburino, Ina von der Heide, Julius Glasmacher, Mohammad Sherif, Philipp Seppelt, Stephan Fichtlscherer, Thomas Walther, Fausto Castriota, Roberto Nerla, Christian Frerker, Tobias Schmidt, Alexander Wolf, Martin M Adamaszek, Francesco Giannini, Maarten Vanhaverbeke, Stefaan Van de Walle, Francis Stammen, Stefan Toggweiler, Stephanie Brunner, Antonio Mangieri, Mauro Gitto, Gerrit Kaleschke, Vlasis Ninios, Ilias Ninios, Judith Hübner, Erion Xhepa, Matthias Renker, Efstratios I Charitos, Michael Joner, Tobias Rheude

BACKGROUND: There is a lack of comparative data on transcatheter aortic valve implantation (TAVI) in degenerated surgical prostheses (valve-in-valve [ViV]). AIMS: We sought to compare outcomes of using two self-expanding transcatheter heart valve (THV) systems for ViV. METHODS: In this retrospective multicentre registry, we included consecutive patients undergoing transfemoral ViV using either the ACURATE neo/neo2 (ACURATE group) or the Evolut R/PRO/PRO+ (EVOLUT group)...

38506737

March 18, 2024: EuroIntervention

#28

JOURNAL ARTICLE

Biological differences of three paclitaxel- and sirolimus-coated balloons on coronary lesions in a rabbit model.

Kazuki Aihara, Sho Torii, Masatoshi Ito, Kaito Koseki, Manabu Shiozaki, Yu Sato, Norihito Nakamura, Ayako Yoshikawa, Yuji Ikari, Gaku Nakazawa

BACKGROUND: Drug-coated balloons (DCBs) are important treatment options for coronary artery disease; however, randomised controlled trials comparing various DCB technologies are sparse, and further investigations are needed. AIMS: This preclinical study aimed to histologically and biologically compare the drug effects and safety of a low-dose paclitaxel-coated DCB (PCB; AGENT), a regular-dose PCB (SeQuent Please NEO) and a sirolimus-coated DCB (SCB; MagicTouch)...

38506736

March 18, 2024: EuroIntervention

#29

JOURNAL ARTICLE

Prophylactic stenting of vulnerable plaques: pros and cons.

Duk-Woo Park, Hoyun Kim, Ayesha Singh, David L Brown

No abstract text is available yet for this article.

38436373

March 4, 2024: EuroIntervention

#30

JOURNAL ARTICLE

Catheter-based versus surgical mitral valve intervention: choosing between the red pill and the blue pill.

Rodrigo Bagur, Angela McInerney

No abstract text is available yet for this article.

38436372

March 4, 2024: EuroIntervention

#31

JOURNAL ARTICLE

Navigating the complexities of antithrombotic therapy after LAAO.

Mohamad Alkhouli

No abstract text is available yet for this article.

38436371

March 4, 2024: EuroIntervention

#32

JOURNAL ARTICLE

Impact of percutaneous mitral paravalvular leak closure on the natural history of recurrent gastrointestinal bleeding.

Yassin Belahnech, Bruno García Del Blanco, Ignacio Ferreira-González, Eduard Ródenas-Alesina, Carmen Alonso-Cotoner, Laura Galian-Gay, María Bermudez-Ramos, Rosa Vila-Olives, Gerard Martí-Aguasca

No abstract text is available yet for this article.

38436370

March 4, 2024: EuroIntervention

#33

JOURNAL ARTICLE

Angiography‑based quantitative flow ratio for functional assessment of intracranial atherosclerotic disease.

Kangmo Huang, Haotao Li, Shengxian Tu, Juan Du, Weihe Yao, Rui Liu, Yunfei Han, Ruidong Ye, Shiteng Suo, Wusheng Zhu, Xinfeng Liu

BACKGROUND: Intracranial atherosclerotic stenosis (ICAS), an important cause of stroke, is associated with a considerable stroke recurrence rate despite optimal medical treatment. Further assessment of the functional significance of ICAS is urgently needed to enable individualised treatment and, thus, improve patient outcomes. AIMS: We aimed to evaluate the haemodynamic significance of ICAS using the quantitative flow ratio (QFR) technique and to develop a risk stratification model for ICAS patients...

38436369

March 4, 2024: EuroIntervention

#34

JOURNAL ARTICLE

Early outcomes of transapical mitral valve implantation versus surgical replacement in matched elderly patients at intermediate surgical risk.

Johannes A Ziegelmueller, Melchior Burri, Andreas Stein, Peter Tassani-Prell, Markus Krane, Rüdiger Lange, Hendrik Ruge

BACKGROUND: Data comparing transcatheter mitral valve implantation (TMVI) with surgical mitral valve replacement (SMVR) are lacking. AIMS: This study sought to compare the 30-day Valve Academic Research Consortium (VARC)-3 device success of TMVI with that of SMVR. METHODS: Matching protocol combined exact matching (sex, atrial fibrillation, previous surgical aortic valve replacement [SAVR] or coronary artery bypass grafting [CABG]), coarsened exact matching (age) and propensity score matching (body mass index, mitral valve pathology and concomitant tricuspid regurgitation)...

38436368

March 4, 2024: EuroIntervention

#35

JOURNAL ARTICLE

Single antiplatelet therapy following Amplatzer left atrial appendage occlusion.

Anders Kramer, Kasper Korsholm, Jens Erik Nielsen-Kudsk

BACKGROUND: The optimal antithrombotic therapy following left atrial appendage occlusion (LAAO) remains debated. Ideally, this therapy should effectively prevent device-related thrombosis (DRT) while minimising the associated bleeding risk. AIMS: We aimed to evaluate the long-term safety and efficacy of a postprocedural single antiplatelet therapy (SAPT) strategy following Amplatzer LAAO in a large consecutive cohort. METHODS: This retrospective, single-centre, observational study included all patients discharged on SAPT after LAAO with the Amplatzer Cardiac Plug (ACP) or Amplatzer Amulet between March 2010 and December 2021 at Aarhus University Hospital, Denmark...

38436367

March 4, 2024: EuroIntervention

#36

JOURNAL ARTICLE

Acute changes in microvascular resistance after treating aortic stenosis.

Nils P Johnson, Rob Eerdekens

No abstract text is available yet for this article.

38436366

March 4, 2024: EuroIntervention

#37

RANDOMIZED CONTROLLED TRIAL

One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial.

Sigrid Sandner, Mario Gaudino, Bjorn Redfors, Dominick J Angiolillo, Ori Ben-Yehuda, Deepak L Bhatt, Stephen E Fremes, Andre Lamy, Riccardo Marano, Roxana Mehran, Stuart Pocock, Sunil V Rao, John A Spertus, Jonathan W Weinsaft, George Wells, Marc Ruel

The optimal antiplatelet strategy after coronary artery bypass graft (CABG) surgery in patients with chronic coronary syndromes (CCS) is unclear. Adding the P2Y12 inhibitor, ticagrelor, to low-dose aspirin for 1 year is associated with a reduction in graft failure, particularly saphenous vein grafts, at the expense of an increased risk of clinically important bleeding. As the risk of thrombotic graft failure and ischaemic events is highest early after CABG surgery, a better risk-to-benefit profile may be attained with short-term dual antiplatelet therapy followed by single antiplatelet therapy...

38436365

March 4, 2024: EuroIntervention

#38

JOURNAL ARTICLE

Between Scylla and Charybdis in atrial functional mitral regurgitation.

Paolo Denti

No abstract text is available yet for this article.

38389477

February 19, 2024: EuroIntervention

#39

JOURNAL ARTICLE

Reply: The ROTA-CUT randomised trial: push the button harder.